AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
2.830
-0.090 (-3.08%)
Aug 1, 2025, 4:00 PM - Market closed
AIM ImmunoTech Stock Forecast
Stock Price Forecast
The 2 analysts that cover AIM ImmunoTech stock have a consensus rating of "Strong Buy" and an average price target of $2.75, which forecasts a -2.83% decrease in the stock price over the next year. The lowest target is $1.00 and the highest is $4.50.
Price Target: $2.75 (-2.83%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 10, 2024.
Analyst Ratings
The average analyst rating for AIM ImmunoTech stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $5 → $4.5 | Strong Buy | Maintains | $5 → $4.5 | +59.01% | Dec 10, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $2 → $1 | Strong Buy | Maintains | $2 → $1 | -64.66% | Oct 22, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $5.25 → $5 | Strong Buy | Maintains | $5.25 → $5 | +76.68% | Sep 3, 2024 |
Financial Forecast
Revenue This Year
202.00K
from 170.00K
Increased by 18.82%
Revenue Next Year
202.00K
from 202.00K
EPS This Year
-0.35
from -30.92
EPS Next Year
-0.46
from -0.35
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 210,000 | 210,000 | 10.2M | ||
| Avg | 202,000 | 202,000 | 9.8M | ||
| Low | 196,000 | 196,000 | 9.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 23.5% | 4.0% | 4,968.3% | ||
| Avg | 18.8% | - | 4,775.2% | ||
| Low | 15.3% | -3.0% | 4,630.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.37 | -0.48 | -0.56 | ||
| Avg | -0.35 | -0.46 | -0.54 | ||
| Low | -0.34 | -0.45 | -0.52 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.